YIPF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.45310430355039E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.04820000002004E-06 |
Normal-vs-Stage2 |
1.719240E-03 |
Normal-vs-Stage3 |
1.27679977701689E-10 |
Normal-vs-Stage4 |
2.24975593710042E-12 |
Stage1-vs-Stage2 |
8.483400E-01 |
Stage1-vs-Stage3 |
9.840700E-04 |
Stage1-vs-Stage4 |
2.09449999999389E-05 |
Stage2-vs-Stage3 |
5.269600E-02 |
Stage2-vs-Stage4 |
4.680500E-03 |
Stage3-vs-Stage4 |
3.011600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.5374002071411E-10 |
Normal-vs-AfricanAmerican |
4.46910286555635E-11 |
Normal-vs-Asian |
6.366400E-01 |
Caucasian-vs-AfricanAmerican |
7.397800E-03 |
Caucasian-vs-Asian |
2.717000E-01 |
AfricanAmerican-vs-Asian |
2.323900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.48376882897128E-12 |
Normal-vs-Female |
7.60120000053988E-07 |
Male-vs-Female |
5.389500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.577200E-04 |
Normal-vs-Age(41-60Yrs) |
1.07830000484199E-08 |
Normal-vs-Age(61-80Yrs) |
8.60309601335985E-11 |
Normal-vs-Age(81-100Yrs) |
1.526410E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.245200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.447800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.307200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.373200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.202000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.216000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.426600E-01 |
Normal-vs-Grade 2 |
4.15299999945162E-07 |
Normal-vs-Grade 3 |
3.17409987182771E-10 |
Normal-vs-Grade 4 |
1.16018306073329E-13 |
Grade 1-vs-Grade 2 |
3.392800E-01 |
Grade 1-vs-Grade 3 |
1.371000E-01 |
Grade 1-vs-Grade 4 |
3.375100E-03 |
Grade 2-vs-Grade 3 |
5.505800E-02 |
Grade 2-vs-Grade 4 |
2.71360000003718E-06 |
Grade 3-vs-Grade 4 |
4.658600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.400780E-03 |
Normal-vs-ccB subtype |
1.26860000282392E-09 |
ccA subtype-vs-ccB subtype |
3.840900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.29350002615092E-09 |
Normal-vs-N1 |
1.500180E-02 |
N0-vs-N1 |
2.541400E-01 |
|
|